Intra-Cellular Therapies Operating Income 2013-2024 | ITCI
- Intra-Cellular Therapies annual operating income for 2023 was $-0.159B, a 39.54% decline from 2022.
- Intra-Cellular Therapies annual operating income for 2022 was $-0.264B, a 7.72% decline from 2021.
- Intra-Cellular Therapies annual operating income for 2021 was $-0.286B, a 23.55% increase from 2020.